Average ASA Status for Orthopedic Procedures by CMS Region

CPT copyright 2010 American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association.Here are statistics on the average ASA status for the top orthopedic procedure in ASCs by CMS region, according to Genascis.

Advertisement


Region 1 (Conn., Mass., Maine, N.H., R.I., Vt.)

Neuroplasty and/or transposition; median nerve at carpal tunnel (CPT 64721) — Status 2

Region 2 (N.J., N.Y., V.I., P.R.)

Arthroscopy, knee, surgical; with meniscectomy, medial OR lateral, including any meniscal shaving (CPT 29881) — Status 2

Region 3 (Del., D.C., Md., Md., Pa., Va., W.Va.)

Arthroscopy, knee, surgical; with meniscectomy, medial OR lateral, including any meniscal shaving (CPT 29881) — Status 2

Region 4 (Ala., Fla., Ga., Ky., Miss., N.C., S.C., Tenn.)

Arthroscopy, knee, surgical; with meniscectomy, medial OR lateral, including any meniscal shaving (CPT 29881) — Status 2

Region 5 (Ill., Ind., Mich., Minn., Ohio, Wis.)

Arthroscopy, knee, surgical; with meniscectomy, medial OR lateral, including any meniscal shaving (CPT 29881) — Status 1

Region 6 (Ark., La., N.M., Okla., Texas)

Arthroscopy, knee, surgical; with meniscectomy, medial OR lateral, including any meniscal shaving (CPT 29881) — Status 1

Region 7 (Iowa, Kan., Mo., Neb.)

Arthroscopy, knee, surgical; with meniscectomy, medial OR lateral, including any meniscal shaving (CPT 29881) — Status 1

Region 8 (Colo., Mont., N.D., S.D., Utah, Wyo.)

Arthroscopy, knee, surgical; with meniscectomy, medial OR lateral, including any meniscal shaving (CPT 29881) — Status 1

Region 9 (A.S., Ariz., Calif., M.P., Guam, Hawaii, Nev.)

Arthroscopy, knee, surgical; with meniscectomy, medial OR lateral, including any meniscal shaving (CPT 29881) — Status 1

Region 10 (Alaska, Idaho, Ore., and Wash.)

Arthroscopy, knee, surgical; with meniscectomy, medial OR lateral, including any meniscal shaving (CPT 29881) — Status 2

Source: Genasics.

Advertisement

Next Up in Compensation Issues

Advertisement

Comments are closed.